| 2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist | 11/21 08:15 | fool.com |
| Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities | 11/21 06:45 | businesswire.com |
| Merck Announces First-Quarter 2025 Dividend | 11/19 12:22 | businesswire.com |
| Merck: Seriously Undervalued At Peak Pessimism (Rating Upgrade) | 11/19 11:28 | seekingalpha.com |
| Merck's Cancer Shot Works. Its Post-Keytruda Plans Are Shaping Up Again. | 11/19 10:49 | barrons.com |
| Injectable version of cancer drug Keytruda works as well as current IV form: Merck | 11/19 08:11 | youtube.com |
| Merck says blockbuster cancer drug met main goals in trial of new under-the-skin formulation | 11/19 07:54 | marketwatch.com |
| Merck says Keytruda injection on par with approved IV version in trial | 11/19 06:49 | reuters.com |
| Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints | 11/19 06:45 | businesswire.com |
| Merck Gets Positive CHMP Opinion for Keytruda in Mesothelioma | 11/18 11:35 | zacks.com |